← All stocks

ROCKET PHARMACEUTICALS, INC.

RCKT Net selling

CIK 0001281895 #3320 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$266.35K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$266.35K

3 of 3 sales

Net

−$266.35K

−$266.35K against sales at will

By person

21 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Wilson Martin

General Counsel

—

$258.60K (2)

−$258.60K

598,489

0.5452%

$2.04M

+824.5%

Shah Gaurav

CEO

—

$7.75K (1)

−$7.75K

1,056,594

0.9625%

$3.60M

+47.1%

RTW INVESTMENTS, LP entity

Director

—

18,188,457

16.57%

$61.90M

0.0%

Stevens Christopher James

Chief Operating Officer

—

505,784

0.4607%

$1.72M

—

Patel Kinnari

See Remarks

—

468,701

0.4270%

$1.59M

+16.4%

Makker Gotham

Director

—

415,346

0.3784%

$1.41M

+13.5%

Rizvi Syed Ali-aamir

Chief Medical Officer

—

407,874

0.3716%

$1.39M

—

Schwartz Jonathan David

See Remarks

—

299,064

0.2724%

$1.02M

+79.1%

Chaudhuri Sarbani

See Remarks

—

262,809

0.2394%

$894.34K

+65.0%

SOUTHWELL DAVID P

Director

—

204,522

0.1863%

$695.99K

+12,221%

Ondrey Aaron

Chief Financial Officer

—

128,173

0.1168%

$436.17K

+174.0%

Militello John

See Remarks

—

89,780

0.0818%

$305.52K

+74.5%

Fong Peter

Director

—

76,195

0.0694%

$259.29K

—

WONG RODERICK

Director

—

75,499

0.0688%

$256.92K

—

White Mark Andrew

See Remarks

—

69,140

0.0630%

$235.28K

−4.3%

Dolsten Mikael

Director

—

67,082

0.0611%

$228.28K

—

GRANADILLO PEDRO P

Director

—

54,734

0.0499%

$186.26K

—

Malik Fady Ibraham

Director

—

52,862

0.0482%

$179.89K

—

BOESS CARSTEN

Director

—

52,862

0.0482%

$179.89K

—

Bjork Elisabeth

Director

—

50,000

0.0455%

$170.15K

—

Pratumsuwan Piratip

Director

—

30,000

0.0273%

$102.09K

—

ROCKET PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out